Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1992 2
1995 3
1997 1
1998 1
1999 2
2000 2
2003 1
2005 5
2006 3
2007 3
2008 2
2009 4
2010 5
2011 3
2012 7
2013 10
2014 14
2015 9
2016 10
2017 4
2018 5
2019 2
2020 4
2021 5
2022 3
2023 3
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.
Howard JF Jr, Bril V, Vu T, Karam C, Peric S, Margania T, Murai H, Bilinska M, Shakarishvili R, Smilowski M, Guglietta A, Ulrichts P, Vangeneugden T, Utsugisawa K, Verschuuren J, Mantegazza R; ADAPT Investigator Study Group. Howard JF Jr, et al. Lancet Neurol. 2021 Jul;20(7):526-536. doi: 10.1016/S1474-4422(21)00159-9. Lancet Neurol. 2021. PMID: 34146511 Clinical Trial.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
[Epidemiology of myasthenia gravis].
Pekmezović T, Lavrnić D, Jarebinski M, Apostolski S. Pekmezović T, et al. Among authors: lavrnic d. Srp Arh Celok Lek. 2006 Sep-Oct;134(9-10):453-6. Srp Arh Celok Lek. 2006. PMID: 17252917 Free article. Review. Serbian.
Guillain-Barré syndrome in the elderly.
Peric S, Berisavac I, Stojiljkovic Tamas O, Rajic S, Babic M, Cvijanovic M, Dominovic-Kovacevic A, Basta I, Beslac-Bumbasirevic L, Lavrnic D. Peric S, et al. Among authors: lavrnic d. J Peripher Nerv Syst. 2016 Jun;21(2):105-10. doi: 10.1111/jns.12163. J Peripher Nerv Syst. 2016. PMID: 26880714
COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis.
Peric S, Rankovic M, Bozovic I, Radosavljevic V, Marjanovic I, Basta I, Lavrnic D. Peric S, et al. Among authors: lavrnic d. Acta Neurol Belg. 2023 Apr;123(2):529-536. doi: 10.1007/s13760-022-02121-w. Epub 2022 Oct 24. Acta Neurol Belg. 2023. PMID: 36279094 Free PMC article.
Diabetes mellitus may affect short-term outcome of Guillain-Barré syndrome.
Peric S, Bozovic I, Bjelica B, Berisavac I, Stojiljkovic O, Basta I, Beslac-Bumbasirevic L, Rakocevic-Stojanovic V, Lavrnic D, Stevic Z. Peric S, et al. Among authors: lavrnic d. J Peripher Nerv Syst. 2017 Jun;22(2):127-130. doi: 10.1111/jns.12206. J Peripher Nerv Syst. 2017. PMID: 28177572
Multidimensional aspects of pain in myotonic dystrophies.
Peric M, Peric S, Rapajic N, Dobricic V, Savic-Pavicevic D, Nesic I, Radojicic S, Novakovic I, Lavrnic D, Rakocevic-Stojanovic V. Peric M, et al. Among authors: lavrnic d. Acta Myol. 2015 Dec;34(2-3):126-32. Acta Myol. 2015. PMID: 27199540 Free PMC article.
Childhood-onset myasthenia gravis with thymoma.
Nikolic DM, Nikolic AV, Lavrnic DV, Medjo BP, Ivanovski PI. Nikolic DM, et al. Among authors: lavrnic dv. Pediatr Neurol. 2012 May;46(5):329-31. doi: 10.1016/j.pediatrneurol.2012.02.025. Pediatr Neurol. 2012. PMID: 22520357
99 results